Hutchison Baiyunshan To Hand Out Medicine Coupons
This article was originally published in PharmAsia News
Amid the financial crisis, billionaire Li Ka-shing's Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine will issue 6 million medicine coupons worth RMB 30 million nationwide to alleviate the burden of drug expenses for people in China. Consumers can get coupons with a face value of RMB 10-20 to purchase designated Hutchison Baiyunshan-made drugs. This is the first coupon distribution program targeting branded-drug consumption in the country. The exercise will allow the company to promote its products, capture funds, as well as benefit users. Analysts note that it has been Li's style to give profits back to consumers during past economic downturns. (Click here for more - Chinese Language)
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.